The Power of Two: Effective Management of Severe Refractory Psoriasis Through Combined TYK2 and IL-23 Inhibition. J of Skin [Internet]. 2025 Sep. 7 [cited 2025 Nov. 6];9(5):2669-73. Available from: https://skin.dermsquared.com/skin/article/view/3446